Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LF3K
|
|||
| Former ID |
DIB010450
|
|||
| Drug Name |
A/Anhui/05
|
|||
| Synonyms |
Inactivated H5N1 avian influenza vaccine, NIAID
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1 | [1] | |
| Company |
Glaxosmithkline; novavax; vaxart
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Influenza Hemagglutinin (Influ HA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00912496) Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59. U.S. National Institutes of Health. | |||
| REF 2 | A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses. J Virol. 2012 March; 86(6): 2978-2989. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.